Biocorrx Inc (BICX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 635 | 178 | 135 | 0 | 0 |
| Cost of Goods | 359 | N/A | 0 | N/A | N/A |
| Gross Profit | 276 | 178 | 0 | 0 | N/A |
| Operating Expenses | 2,581 | 1,592 | 1,073 | 1,125 | 1,660 |
| Operating Income | -1,946 | -1,414 | -938 | -1,125 | -1,660 |
| Interest Expense | 225 | 201 | 248 | 330 | 307 |
| Other Income | 1,362 | 238 | 334 | 227 | 454 |
| Pre-tax Income | -809 | -1,377 | -852 | -1,228 | -1,513 |
| Net Income Continuous | -809 | -1,377 | -852 | -1,228 | -1,513 |
| Minority Interests | 1,109 | -144 | -10 | -63 | -26 |
| Net Income | $-1,918 | $-1,233 | $-841 | $-1,165 | $-1,487 |
| EPS Basic Total Ops | -0.11 | -0.07 | -0.06 | -0.08 | -0.14 |
| EPS Basic Continuous Ops | -0.04 | -0.08 | -0.06 | -0.09 | -0.14 |
| EPS Diluted Total Ops | -0.11 | -0.07 | -0.06 | -0.08 | -0.14 |
| EPS Diluted Continuous Ops | -0.04 | -0.08 | -0.06 | -0.09 | -0.14 |
| EPS Diluted Before Non-Recurring Items | -0.11 | -0.07 | -0.06 | -0.08 | -0.14 |
| EBITDA(a) | $-1,740 | $-1,212 | $-737 | $-879 | $-1,424 |